# Effectiveness and Safety of Zingiber Officinale Transdermal Patch for Acne Vulgaris; Study of Interleukin 1 and Skin Microbiome

> **NCT06787222** · PHASE2,PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Hasanuddin University** · enrollment: 26 (estimated)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** tretinoin 0.025% + Z. officinale patch
- **DRUG:** tretinoin 0.025% cream

## Key facts

- **NCT ID:** NCT06787222
- **Lead sponsor:** Hasanuddin University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-11-03
- **Primary completion:** 2025-08-25
- **Final completion:** 2025-10-31
- **Target enrollment:** 26 (ESTIMATED)
- **Last updated:** 2025-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06787222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06787222, "Effectiveness and Safety of Zingiber Officinale Transdermal Patch for Acne Vulgaris; Study of Interleukin 1 and Skin Microbiome". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT06787222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
